3,3′-Diindolylmethane induces a G1 arrest in human prostate cancer cells irrespective of androgen receptor and p53 status

被引:48
作者
Vivar, Omar I. [1 ]
Lin, Chia-Lei [1 ]
Firestone, Gary L. [2 ]
Bjeldanes, Leonard F. [1 ]
机构
[1] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA
关键词
3,3 '-Diindolylmethane; Prostate cancer; Cell cycle arrest; p27(Kip1); p38; MAPK; Cancer; CYCLE ARREST; MOLECULAR-MECHANISM; GENE PROMOTER; KINASE; P38; EXPRESSION; ACTIVATION; GROWTH; PROTEIN; SP1;
D O I
10.1016/j.bcp.2009.05.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3,3'-Diindolymethane (DIM) is a potential chemopreventive phytochemical derived from Brassica vegetables. In this study we characterized the effect of DIM on cell cycle regulation in both androgen-dependent LNCaP and androgen receptor negative p53 mutant DU145 human prostate cancer cells. DIM had an anti-proliferative effect on both LNCaP and DU145 cells, as it significantly inhibited [H-3]-thymidine incorporation. FACS analysis revealed a DIM-mediated G, cell cycle arrest. DIM strongly inhibited the expression of cdk2 and cdk4 protein and increased the expression of the cell cycle inhibitor p27(Kip1) protein in LNCaP and DU145 cells. Promoter deletion Studies with p27(Kip1) reporter gene constructs showed that this DIM-mediated increase in p27(Kip1) was dependent on the Sp1 transcription factor. Moreover, using a dominant negative inhibitor of p38 MAN, we showed that the induction Of P27(Kip1) and Subsequent G, arrest by DIM involve activation of the p38 MAPK pathway in the DU145 cells. Taken together, our results indicate that DIM is able to stop the cell cycle progression Of human prostate cancer cells regardless of their androgen-dependence and p53 status, by differentially modulating cell cycle regulatory pathways. The Sp1 and p38 MAPK pathways mediate the DIM cell cycle regulatory effect in DU145 cells. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 32 条
[1]  
Auborn KJ, 2002, ANTIVIR THER, V7, P1
[2]   PKCδ mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle [J].
Bowles, D. K. ;
Maddali, K. K. ;
Dhulipala, V. C. ;
Korzick, D. H. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (02) :C805-C813
[3]   3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice [J].
Chang, XF ;
Tou, JC ;
Hong, CB ;
Kim, HA ;
Riby, JE ;
Firestone, GL ;
Bjeldanes, LF .
CARCINOGENESIS, 2005, 26 (04) :771-778
[4]   Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling [J].
Cover, CM ;
Hsieh, SJ ;
Tran, SH ;
Hallden, G ;
Kim, GS ;
Bjeldanes, LF ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :3838-3847
[5]   Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter [J].
Cram, EJ ;
Liu, BD ;
Bjeldanes, LF ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22332-22340
[6]   Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression [J].
Cvoro, A ;
Tzagarakis-Foster, C ;
Tatomer, D ;
Paruthiyil, S ;
Fox, MS ;
Leitman, DC .
MOLECULAR CELL, 2006, 21 (04) :555-564
[7]   Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle [J].
Dadlani, Harsha ;
Ballinger, Mandy L. ;
Osman, Narin ;
Getachew, Robel ;
Little, Peter J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (12) :7844-7852
[8]   NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways [J].
Daly, JM ;
Olayioye, MA ;
Wong, AML ;
Neve, R ;
Lane, HA ;
Maurer, FG ;
Hynes, NE .
ONCOGENE, 1999, 18 (23) :3440-3451
[9]   Annual report to the Nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment [J].
Edwards, BK ;
Brown, ML ;
Wingo, PA ;
Howe, HL ;
Ward, E ;
Ries, LAG ;
Schrag, D ;
Jamison, PM ;
Jemal, A ;
Wu, XC ;
Friedman, C ;
Harlan, L ;
Warren, J ;
Anderson, RN ;
Pickle, LW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) :1407-1427
[10]   The development of androgen-independent prostate cancer [J].
Feldman, BJ ;
Feldman, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :34-45